THE NUCLEUS BASALIS OF MEYNERT IN NEUROLOGICAL DISEASE - A QUANTITATIVE MORPHOLOGICAL-STUDY
THE NUCLEUS BASALIS OF MEYNERT IN NEUROLOGICAL DISEASE - A QUANTITATIVE MORPHOLOGICAL-STUDY
复制标题
DOI:
10.1002/ana.410170210
复制
发表时间:
1985-01-01
影响因子:
11.2
通讯作者:
MIRRA, SS
中科院分区:
文献类型:
--
作者:
ROGERS, JD;BROGAN, D;MIRRA, SS
The recent finding of neuronal degeneration in the nucleus basalis of Meynert (nbM) in Alzheimer''s disease suggests a possible role of this nucleus and the cholinergic system in dementing illness. Neuronal population and density were assessed in 2 anatomical levels of the nbM in 38 coded brains from patients with a broad variety of neurological disorders. The most striking nbM degeneration was found in Alzheimer''s and Parkinson''s diseases. An intermediate loss of neurons was noted in the transmissible dementia Creutzfeldt-Jakob disease and in progressive supranuclear palsy. The usually nondementing diseases amyotrophic lateral sclerosis and multiple sclerosis showed cell counts comparable to those in a control group of nondemented patients with cerebrovascular disease. Characteristic neuropathological changes of Alzheimer''s, Parkinson''s and Creutzfeldt-Jakob diseases, progressive supranuclear palsy and subacute sclerosing panencephalitis were also found in the nbM. Most previous studies of the nbM have been based on small numbers of cases compared with controls. In the present large series consistent methodology and a multiple-comparison statistical procedure were used to avoid overreporting of statistical significance. The marked degeneration of the nbM in Alzheimer''s disease is confirmed. such degeneration is placed into perspective in a spectrum of dementing and nondementing neurological diseases. Larger case studies, using appropriate statistical techniques for multiple group comparisons, are needed to establish the significance of nbM degeneration in neurological disease.